Call Start: 08:30 January 1, 0000 9:24 AM ET BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2022 Earnings Conference Call May 5, 2022 08:30 AM ET Company Participants John Bluth - SVP, IR and Corporate Communications Jon Stonehouse - Chief Executive Officer Anthony Doyle - Chief Financial Officer Dr. Bill Sheridan - Chief Medical Officer Charlie Gayer - Chief Commercial Officer Dr. Helen Thackray - Chief R&D Officer Conference Call Participants Ken Cacciatore - Cowen and Company Jon Wolleben - JMP Securiti ...